Patent: 9,872,895
✉ Email this page to a colleague
Summary for Patent: 9,872,895
Title: | TLR5 ligands, therapeutic methods, and compositions related thereto |
Abstract: | The disclosure relates to antiviral therapeutic methods and related compositions. In certain embodiments, the disclosure relates to methods of treating or preventing a viral infection by administering a pharmaceutical composition comprising a TLR5 ligand, such as a flagellin, to a subject in need thereof. |
Inventor(s): | Gewirtz; Andrew T. (Smyrna, GA), Zhang; Benyue (Liburn, GA) |
Assignee: | Emory University (Atlanta, GA) |
Application Number: | 13/825,349 |
Patent Claims: | see list of patent claims |
Details for Patent 9,872,895
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Zr Pharma& Gmbh | PEGASYS | peginterferon alfa-2a | Injection | 103964 | 10/16/2002 | ⤷ Try a Trial | 2030-09-24 |
Zr Pharma& Gmbh | PEGASYS | peginterferon alfa-2a | Injection | 103964 | 01/07/2004 | ⤷ Try a Trial | 2030-09-24 |
Zr Pharma& Gmbh | PEGASYS | peginterferon alfa-2a | Injection | 103964 | 09/29/2011 | ⤷ Try a Trial | 2030-09-24 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |